BeiGene

ONC · NASDAQ🇨🇭

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 27 days ago

Total Revenue

$1.5B

Previous year: $1.13B

+32.8%

EPS

$1.95

Previous year: -$0.11

Previous year: $2.64B

+74.7%

Free Cash Flow

$380M

Previous year: $75.2M

+405.4%

Total Assets

$8.19B

Previous year: $5.92B

+38.3%

Loading...

BeiGene

Unlock previous datapoints

Upgrade

BeiGene

Unlock previous datapoints

Upgrade

BeiGene Revenue by Segment

BeiGene Revenue by Geographic Location

Revenue by Segment

BRUKINSA Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

TEVIMBRA Revenue

CapyFin.com

Amgen In-Licensed Revenue

CapyFin.com

Revenue by Geographic Location

U.S. BRUKINSA Sales Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$28B

P/E Ratio

-604.45

Sector

N/A

Industry

N/A

52-Week High

$377

52-Week Low

$208

R&D Expenses

$615M

SG&A Expenses

$555M

GAAP Gross Margin

90.4%

Products

Get in Touch

Resources

BeiGene

BeiGene

BeiGene

BeiGene Revenue by Segment

BeiGene Revenue by Geographic Location

Revenue by Segment

BRUKINSA Revenue

TEVIMBRA Revenue

Amgen In-Licensed Revenue

Revenue by Geographic Location

U.S. BRUKINSA Sales Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics